About Dean Eliott, MD

Director of the Mass. Eye and Ear Retina Service, Dr. Dean Eliott enjoys a national reputation as a gifted vitreoretinal surgeon and is sought by colleagues for difficult surgical cases. He is especially interested in treating retinal detachment, diabetic retinopathy, non-diabetic retinal vascular disease, trauma, and complex surgical problems.

After receiving his medical training from Vanderbilt University School of Medicine, Dr. Eliott completed his ophthalmology residency at Wilmer Eye Institute/Johns Hopkins Hospital. This was followed by a vitreoretinal fellowship at Duke University where he was also Chief Resident and a faculty member. Dr. Eliott then spent twelve years on the faculty at Kresge Eye Institute in Detroit where he was Director of the Retina Service and Retina Fellowship Director. Before coming to Mass. Eye and Ear, Dr. Eliott was Professor of Ophthalmology, Director of Clinical Affairs, and Director of Vitreoretinal Fellowship at the University of Southern California Keck School of Medicine's Doheny Eye Institute in Los Angeles.

Dr. Eliott co-directs the Diabetic Eye Disease Center of Excellence at Harvard Medical School-a multidisciplinary collaboration among clinicians and scientists who are pooling their knowledge and resources with the goal of advancing breakthroughs in treatment for patients with diabetic eye disease. Additionally, he plays an important role training ophthalmology residents and fellows in the clinic and in the operating room as Director of the Retina Fellowship and Co-Director of Mass. Eye and Ear's Vitrectomy Course. He also is a sought after regional, national, and international speaker.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Mass Eye and Ear
243 Charles St.
Boston, MA 02114
Phone: 617-523-7900

Medical Education

  • MD, Vanderbilt University School of Medicine
  • Residency, Wilmer Eye Institute at Johns Hopkins
  • Fellowship, Duke University Medical Center

American Board Certifications

  • Ophthalmology, American Board of Ophthalmology

Research

Dr. Eliott is an accomplished and nationally renowned vitreoretinal surgeon. He is active in clinical trials for retinal disease, with a strong interest in translational research on diabetic retinopathy, AMD, non-diabetic retinal vascular disease, and proliferative vitreoretinopathy. His recent work includes studies to improve diagnosis and outcomes in patients with proliferative diabetic retinopathy, diabetic macular edema, and complex vitreoretinal surgical conditions, such as diabetic retinal detachment, trauma, endophthalmitis, and recurrent retinal detachment due to proliferative vitreoretinopathy.

Publications

  • 1. Tieger MG, Moussa K, Kim LA, Eliott D. The History of Visualization in Vitrectomy Surgery. Int Ophthalmol Clin. 2020; 60(1):1-15.

    2. Wang JC, Ryan EH, Ryan C, Kakulavarapu S, Mardis PJ, Rodriguez M, Stefater JA, Forbes NJ, Gupta O, Capone A, Emerson GG, Joseph DP, Eliott D, Yonekawa Y. FACTORS ASSOCIATED WITH THE USE OF 360-DEGREE LASER RETINOPEXY DURING PRIMARY VITRECTOMY WITH OR WITHOUT SCLERAL BUCKLE FOR RHEGMATOGENOUS RETINAL DETACHMENT AND IMPACT ON SURGICAL OUTCOMES (PRO STUDY REPORT NUMBER 4). Retina. 2019 Dec 23. 

    3. Reshef ER, Habib LA, Rao R, Modjtahedi BS, Eliott D, Freitag SK, Reinshagen KL, Lee NG. Clinical and radiographic features of hydrolyzed MIRAgel scleral buckles: A comparative analysis. Clin Imaging. 2019 Dec 06; 60(1):10-15.

    4. Rong AJ, Fan KC, Golshani B, Bobinski M, McGahan JP, Eliott D, Morse LS, Modjtahedi BS. Multimodal imaging features of intraocular foreign bodies. Semin Ophthalmol. 2019; 34(7-8):518-532.

    5. Ung C, Stryjewski TP, Eliott D. Indications, Findings, and Outcomes of Pars Plana Vitrectomy after Open Globe Injury. Ophthalmol Retina. 2019 Sep 10. 

    View more

Reviews: Comments and Ratings